[1] |
Lefkowitch JH. The pathology of acute liver failure[J]. Adv Anat Pathol, 2016, 23(3):144-158.
|
[2] |
Li XM, Ma L, Yang YB, et al. Clinical characteristics of fulminant hepatitis in pregnancy[J]. World J Gastroenterol, 2005, 11(29):4600-4603.
|
[3] |
Jin H, Zhao Y, Zhang X, et al. Case-fatality risk of pregnant women with acute viral hepatitis type E: a systematic review and meta-analysis[J]. Epidemiol Infect, 2016, 144(10):2098-2106.
|
[4] |
Khuroo MS, Khuroo MS, Khuroo NS. Discovery, global impact, control and cure[J]. World J Gastroenterol, 2016, 22(31):7030-7045.
|
[5] |
Licata A, Ingrassia D, Serruto A, et al. Clinical course and management of acute and chronic viral hepatitis during pregnancy[J]. J Viral Hepat, 2015, 22(6):515-523.
|
[6] |
Halliday J, Lokan J, Angus PW, et al. A case of fulminant hepatic failure in pregnancy[J]. Hepatology, 2010, 51(1):341-342.
|
[7] |
李小毛. 妊娠合并重型肝炎的治疗现状及进展[J]. 新医学,2005, 36(2):65-67.
|
[8] |
马洁,刘建. 妊娠合并重症肝炎的诊治进展[J]. 医学信息,2014, 27(4):495-496.
|
[9] |
郝秀兰,侯红瑛. 关于妊娠合并重症肝炎[J/CD]. 中华产科急救电子杂志,2012, 1(1):14-16.
|
[10] |
尹玉竹,周瑾. 妊娠合并肝衰竭的产科处理[J/CD]. 中华产科急救电子杂志,2014, 3(3):172-175.
|
[11] |
黄琳琳,刘建. 妊娠合并重症肝炎治疗进展[J]. 中外医疗,2015, (11):194-196.
|
[12] |
McCormick PA, Donnelly C. Management of hepatorenal syndrome[J]. Pharmacol Ther, 2008, 119(1):1-6.
|
[13] |
Li M, Sun J, Li J, et al. Clinical observation on the treatment of acute liver failure by combined non-biological artificial liver[J]. Exp Ther Med, 2016, 12(6):3873-3876.
|
[14] |
Komura T, Taniguchi T, Sakai Y, et al. Efficacy of continuous plasma diafiltration therapy in critical patients with acute liver failure[J]. J Gastroenterol Hepatol, 2014, 29(4):782-786.
|
[15] |
Wu DB, Chen EQ, Bai L, et al. Propylthiouracil-induced liver failure and artificial liver support systems: a case report and review of the literature[J]. Ther Clin Risk Manag, 2017, 13:65-68.
|
[16] |
Mendizabal M, Rowe C, Piñero F, et al. Successful orthotopic liver transplantation and delayed delivery of a healthy newborn in a woman with fulminant hepatic failure during the second trimester of pregnancy[J]. Ann Hepatol, 2014, 13(2):288-292.
|
[17] |
唐晖,傅斌生,易慧敏,等. 肝移植治疗妊娠期合并急性肝衰竭2例并文献复习[J]. 器官移植,2015, 6(6):388-391.
|
[18] |
Mendizabal M, Silva MO. Liver transplantation in acute liver failure: A challenging scenario[J]. World J Gastroenterol, 2016, 22(4):1523-1531.
|
[19] |
Fukumitsu K, Yagi H, Soto-Gutierrez A.Bioengineering in organ transplantation: targeting the liver[J]. Transplant Proc, 2011,43(6):2137-2138.
|
[20] |
Pan CQ, Lee HM. Antiviral therapy for chronic hepatitis B in pregnancy[J]. Semin Liver Dis, 2013, 33(2):138-146.
|
[21] |
Pan CQ, Han GR, Jiang HX, et al. Telbivudine prevents vertical transmission from HBeAg-positive women with chronic hepatitis B[J]. Clin Gastroenterol Hepatol, 2012, 10(5):520-526.
|
[22] |
Han GR, Jiang HX, Wang CM, et al. Long-term safety and efficacy of telbivudine in infants born to mothers treated during the second or third trimesters of pregnancy[J]. J Viral Hepat, 2017, 24(2):514-521.
|
[23] |
Han GR, Cao MK, Zhao W, et al. A prospective and open-label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection[J]. J Hepatol, 2011, 55(6):1215-1221.
|
[24] |
Han GR, Jiang HX, Yue X, et al. Efficacy and safety of telbivudine treatment: an open-label, prospective study in pregnant women for the prevention of perinatal transmission of hepatitis B virus infection[J]. J Viral Hepat, 2015, 22(9):754-762.
|
[25] |
Xu WM, Cui YT, Wang L, et al. Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double-blind, placebo-controlled study[J]. J Viral Hepat, 2009, 16(2):94-103.
|
[26] |
Tran TT. Management of hepatitis B in pregnancy: weighing the options[J]. Cleve Clin J Med, 2009, 76(Suppl 3):S25-S29.
|
[27] |
Pan CQ, Duan Z, Dai E, et al. Tenofovir to prevent hepatitis b transmission in mothers with high viral load[J]. N Engl J Med, 2016, 374(24):2324-2334.
|
[28] |
Chang ML, Liaw YF. Hepatitis B flares in chronic hepatitis B: pathogenesis, natural course, and management[J]. J Hepatol, 2014, 61(6):1407-1417.
|
[29] |
Han GR, Xu CL, Zhao W, et al. Management of chronic hepatitis B in pregnancy[J]. World J Gastroenterol, 2012, 18(33):4517-4521.
|
[30] |
韩国荣,丁祎. 慢性乙型肝炎育龄妇女及孕妇的抗病毒治疗指征与时机的选择[J]. 中华肝脏病杂志,2015, 23(11):806-809.
|
[31] |
Chen H, Yuan L, Tan J, et al. Severe liver disease in pregnancy[J]. Int J Gynaecol Obstet, 2008, 101(3):277-280.
|
[32] |
李小毛. 晚期妊娠合并重型肝炎产科处理的若干问题[J].广东医学,2007, 28(5):683-684.
|
[33] |
Deng L, Li X, Shi Z, et al. Maternal and perinatal outcome in cases of fulminant viral hepatitis in late pregnancy[J]. Int J Gynaecol Obstet, 2012, 119(2):145-148.
|
[34] |
Labrique AB, Sikder SS, Krain LJ, et al. Hepatitis E, a vaccine preventable cause of maternal deaths[J]. Emerg Infect Dis, 2012, 18(9):1401-1404.
|
[35] |
Kumar M, Singh T, Sinha S. Chronic hepatitis B virus infection and pregnancy[J]. J Clin Exp Hepatol, 2012, 2(4):366-381.
|